AI assistant
Sending…
USBC, Inc. — Director's Dealing 2023
Mar 16, 2023
33069_dirs_2023-03-16_484298c9-3666-422f-8bf0-34b0e1acb4f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KNOW LABS, INC. (KNWN)
CIK: 0001074828
Period of Report: 2023-03-15
Reporting Person: Trautwein Leonardo Mouta (Chief Marketing Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-15 | Common Stock | P | 6000 | $0.8399 | Acquired | 19980 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Purchase Common Stock | $2.04 | 2026-02-04 | Common Stock (200000) | 200000 | Direct |
| Option to Purchase Common Stock | $2.35 | 2026-02-09 | Common Stock (100000) | 100000 | Direct |
| Option to Purchase Common Stock | $2.09 | 2026-12-16 | Common Stock (100000) | 100000 | Direct |
| Option to Purchase Common Stock | $1.48 | 2027-05-20 | Common Stock (600000) | 600000 | Direct |
Footnotes
F1: Options vest quarterly over four years. No vesting during first 6 months.
F2: Options vest upon FDA approval
F3: Options vest quarterly over four years.
More from USBC, Inc.
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 27
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 26
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Jan 26